CRP and COVID-19: As evaluated during the acute phase of COVID-19, patients with moderate forms of severity prevailed (76.47%, p < 0.001); based on the CCT, they had a more severe pulmonary injury and higher degrees of inflammation, with more increased CRP (p < 0.001).